| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |